Stent graft for dialysis access problems
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial tests a special stent graft called WRAPSODY CIE to treat narrowed or blocked veins in the arm used for dialysis. It aims to keep your access working well so you can continue receiving hemodialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to be on chronic hemodialysis using a mature access that has been used at least once.
- You have a narrowing or blockage in the vein draining your dialysis access.
- You must be willing to follow standard care and return for check-ups over the next 3 years.
- You cannot have an upcoming kidney transplant or switch to peritoneal dialysis within 6 months.
- You should not have any known allergies to nickel or titanium.
- You must not have an active infection at your access site or in your blood.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new stent to open narrowed or blocked areas in dialysis access (fistula or graft). It may help improve blood flow so dialysis works better.
This trial tests a new device called the Velocity pAVF System that creates a connection between a vein and artery in your arm for hemodialysis. If you need dialysis now or within the next 6 months, this could be a new option for you.
This trial studies a procedure to open up blocked or narrowed areas in the plastic tube (graft) used for dialysis. It aims to see if the procedure works well and if it is cost-effective for patients who have trouble completing dialysis because of graft issues.
This trial tests a special wrap placed around a new arm access point for dialysis (called an AV fistula) to see if it helps the access stay healthy and work better. It is for people who need a new AV fistula for kidney dialysis.
This trial compares two ways to reopen a blocked “dialysis access” vessel in the upper arm after a clot is treated. It may help keep blood flowing in the access longer and reduce the chance of re-blockage.
This trial tests a new artificial graft device designed to create a reliable access point in your arm for hemodialysis if you have end-stage kidney disease. The graft connects an artery to a vein, allowing easier and safer blood flow during dialysis treatments.
Hear when a new Venous Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.